• Search
  • Advanced Search
Clin Mol Hepatol > Accepted Articles
Editorial
Incretin-based therapy in the management of metabolic dysfunction-associated steatotic liver disease (MASLD): one piece of the puzzle
Tian-Yi Ren1, Mohammed Eslam2, Jian-Gao Fan1,3
1Department of Gastroenterology, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China
2Storr Liver Centre, Westmead Institute for Medical Research, Westmead Hospital and University of Sydney, NSW, Australia
3Shanghai Key Lab of Pediatric Gastroenterology and Nutrition, Shanghai, China
Correspondence :  Jian-Gao Fan ,
Email: fanjiangao@xinhuamed.com.cn
Received: July 14, 2024   Accepted: July 20, 2024
TOOLS
METRICS Graph View
  • 0 Crossref
  •  0 Scopus
  • 698 View
  • 35 Download
Related articles

Metabolic dysfunction-associated steatotic liver disease exhibits sex-specific microbial heterogeneity within intestinal compartments

Essential tools for assessing advanced fibrosis in metabolic dysfunction-associated steatotic liver disease

Reply to the correspondence on editorial regarding “Incretin-based therapy in the management of MASLD: one piece of the puzzle”

Sex-specific associations of metabolic dysfunction-associated steatotic liver disease with cardiovascular outcomes

Correspondence on Editorial regarding “Incretin-based therapy in the management of MASLD: one piece of the puzzle”

Editorial Office
The Korean Association for the Study of the Liver
Room A1210, 53 Mapo-daero(MapoTrapalace, Dowha-dong), Mapo-gu, Seoul, 04158, Korea
TEL: +82-2-703-0051   FAX: +82-2-703-0071    E-mail: kasl@kams.or.kr
Copyright © The Korean Association for the Study of the Liver.         
COUNTER
TODAY : 508
TOTAL : 2102107
Close layer